Elutia Completes SimpliDerm® Sale on Schedule, Adds $8 Million in Cash to Fund NXT-41x Through Full Commercial Launch
Go back to Elutia Completes SimpliDerm® Sale on Schedule, Adds $8 Million in Cash to Fund NXT-41x Through Full Commercial Launch| (NASDAQ: ELUT) | Delayed: 0.86 +0.04 (4.88%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $0.82 | 52 Week High | $ | |||
| Open | $0.84 | 52 Week Low | $ | |||
| Day High | $0.86 | P/E | N/A | |||
| Day Low | $0.76 | EPS | $ | |||
| Volume | 52,619 | |||||



